These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31779292)

  • 1. The Co-Constitution of Health Systems and Innovation Comment on "What Health System Challenges Should Responsible Innovation in Health Address? Insights From an International Scoping Review".
    Peine A
    Int J Health Policy Manag; 2019 Nov; 8(11):665-667. PubMed ID: 31779292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovation, Demand, and Responsibility: Some Fundamental Questions About Health Systems Comment on "What Health System Challenges Should Responsible Innovation in Health Address? Insights From an International Scoping Review".
    van Lente H
    Int J Health Policy Manag; 2019 Sep; 8(9):567-569. PubMed ID: 31657181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovation Strategies and Health System Guiding Principles to Address Equity and Sustainability in Responsible Innovation in Health Comment on "What Health System Challenges Should Responsible Innovation in Health Address? Insights From an International Scoping Review".
    Buttigieg SC
    Int J Health Policy Manag; 2019 Sep; 8(9):570-572. PubMed ID: 31657182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who is Responsible for Responsible Innovation? Lessons From an Investigation into Responsible Innovation in Health Comment on "What Health System Challenges Should Responsible Innovation in Health Address? Insights From an International Scoping Review".
    Stahl BC
    Int J Health Policy Manag; 2019 Jul; 8(7):447-449. PubMed ID: 31441281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nurturing Societal Values in and Through Health Innovations Comment on "What Health System Challenges Should Responsible Innovation in Health Address?".
    Abrishami P; Repping S
    Int J Health Policy Manag; 2019 Oct; 8(10):613-615. PubMed ID: 31657189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Need for a Dynamic Approach to Health System-Centered Innovations Comment on "What Health System Challenges Should Responsible Innovation in Health Address? Insights From an International Scoping Review".
    van Olmen J; Marchal B; Ricarte B; Van Damme W; Van Belle S
    Int J Health Policy Manag; 2019 Jul; 8(7):444-446. PubMed ID: 31441280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Health System Challenges Should Responsible Innovation in Health Address? Insights From an International Scoping Review.
    Lehoux P; Roncarolo F; Silva HP; Boivin A; Denis JL; Hébert R
    Int J Health Policy Manag; 2019 Feb; 8(2):63-75. PubMed ID: 30980619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Conceptualization of Value in the Value Proposition of New Health Technologies Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies".
    Buttigieg SC; Hoof JV
    Int J Health Policy Manag; 2018 Feb; 7(2):186-188. PubMed ID: 29524943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing responsible innovation in health: a policy-oriented framework.
    Pacifico Silva H; Lehoux P; Miller FA; Denis JL
    Health Res Policy Syst; 2018 Sep; 16(1):90. PubMed ID: 30200985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do we know about the needs and challenges of health systems? A scoping review of the international literature.
    Roncarolo F; Boivin A; Denis JL; Hébert R; Lehoux P
    BMC Health Serv Res; 2017 Sep; 17(1):636. PubMed ID: 28886736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chronic care model and technological research and innovation: a scoping review at the crossroads.
    Gammon D; Berntsen GK; Koricho AT; Sygna K; Ruland C
    J Med Internet Res; 2015 Feb; 17(2):e25. PubMed ID: 25677200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can entrepreneurs experience inform responsible health innovation policies? A longitudinal case study in Canada and Brazil.
    Lehoux P; Silva HP; Miller F; Denis JL; Pozelli RS
    Int J Health Plann Manage; 2023 Jul; 38(4):967-985. PubMed ID: 36992612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health care innovation from a territorial perspective: a call for a new approach].
    Costa LS; Gadelha CA; Maldonado J
    Rev Saude Publica; 2012 Dec; 46 Suppl 1():59-67. PubMed ID: 23250395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment-responsible innovation in health approach in the "new normal".
    Mukherjee K; Walley T
    Int J Technol Assess Health Care; 2022 May; 38(1):e47. PubMed ID: 35549786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Health Technologies: A UK Perspective Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies".
    Parvizi N; Parvizi S
    Int J Health Policy Manag; 2017 Dec; 6(12):721-722. PubMed ID: 29172379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse innovation: an opportunity for strengthening health systems.
    Snowdon AW; Bassi H; Scarffe AD; Smith AD
    Global Health; 2015 Feb; 11(1):2. PubMed ID: 25889986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health System Transformation through a Scalable, Actionable Innovation Strategy.
    Snowdon A
    Healthc Pap; 2017; 16(3):59-64. PubMed ID: 28671547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovation in healthcare: a systematic review of recent research.
    Länsisalmi H; Kivimäki M; Aalto P; Ruoranen R
    Nurs Sci Q; 2006 Jan; 19(1):66-72; discussion 65. PubMed ID: 16407603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare technology co-operatives: Innovative about innovation.
    Heron NM; Tindale WB
    J Med Eng Technol; 2014; 39(7):378-81. PubMed ID: 26453035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological and conceptual issues regarding occupational psychosocial coronary heart disease epidemiology.
    Burr H; Formazin M; Pohrt A
    Scand J Work Environ Health; 2016 May; 42(3):251-5. PubMed ID: 26960179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.